Illumina (ILMN) announced a sequencing agreement with the San Diego Zoo Wildlife Alliance’s Frozen Zoo. The 50-year-old biobank is the world’s most comprehensive and diverse collection of living cells from threatened and endangered species across the animal kingdom. Illumina will sequence up to 4,000 samples representing 1,300 species in the Frozen Zoo. Genomic insights will be applied to real-world conservation challenges and efforts to safeguard animal species worldwide. A subset of samples will be used for groundbreaking multiomic research, geared toward unlocking vital insights into wildlife medicine, evolutionary biology, and biodiversity preservation. Illumina will sequence up to 4,000 samples representing 1,300 species in the Frozen Zoo. The San Diego Zoo Wildlife Alliance has partnered with the International Union for Conservation of Nature Species Survival Commission as a Center for Species Survival focused on biodiversity banking.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- ILMN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Illumina Completes SomaLogic Acquisition, Expands Proteomics Capabilities
- Standard BioTools completes sale of SomaLogic to Illumina
- Cathie Wood Buys the Dip in Joby Aviation (JOBY), Sells Teradyne (TER) Near Highs
- Illumina price target raised to $170 from $144 at Guggenheim
